CD8A and neoplasm: To investigate whether the enhanced stem-like CD8+ T cells in AgkcKO mice could enhance anti-PD1/PD-L1 directed immunotherapy, we treated Agkfl/fland AgkcKO LLC tumor-bearing mice with anti-PD1 antibody at day 5, day 8, and day 10 after tumor transplantation.